UKNoticeOfficial ✓June 19, 2026· GOV.UK
Tribunal was “wrong” to reject CMA phenytoin decision, says Court
What happened
The Court of Appeal decided that the Tribunal was wrong to overturn the CMA's decision regarding its investigation into phenytoin. Phenytoin is described as a "life-saving epilepsy drug."
Why it matters
This ruling means the original investigation into the epilepsy drug by the CMA is back on track. It could impact how decisions are made about the pricing or availability of important medicines.
Who it affects
- ›Epilepsy patients
- ›Drug manufacturers of phenytoin
- ›The Tribunal
Receipts
The receipts are official. The summary is ours.
Read on GOV.UK ↗Summaries are generated from the official text and may simplify or omit nuance. The official document is the source of truth.
More from UK
UKNoticeOfficial ✓
Resident doctors to vote on government offer to end strikesGOV.UK·Jun 19, 2026
UKNoticeOfficial ✓
“Migration is a global challenge requiring global cooperation” says Foreign Secretary, announcing expansion of North Africa programme to support migrants closer to homeGOV.UK·Jun 19, 2026
UKNoticeOfficial ✓
We urge Israel to immediately remove unjustifiable restrictions on humanitarian access: UK statement at the UN Security CouncilGOV.UK·Jun 18, 2026